Impact of Ocrelizumab on Cerebrospinal Fluid Biomarkers at Multiple Sclerosis Onset
Clinical trial NCT04466150 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04466150
- Sponsor
- University of California, San Francisco
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-30
- Primary completion
- 2026-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.